TY - JOUR
T1 - Coccidioidomycosis in human immunodeficiency virus-infected patients
AU - Galgiani, John N.
AU - Ampel, Neil M.
N1 - Funding Information:
Received 5 July 1990; revised 9 July 1990. Financial support: Department of Veterans Affairs. Information regarding treatment of some patients with fluconazole, itraconazole, or SCH 39304 was obtained within treatment protocols designed and carried out by the National Institute of Allergy and Infectious Diseases Mycoses Study Group (NOl-AI-5256). Reprints or correspondence: Dr. John N. Galgiani, Medical Service (111), VA Medical Center, Tucson, AZ 85723.
PY - 1990/11
Y1 - 1990/11
N2 - Note From Dr. Merle. A. Sande –Coccidioidomycosis is at best a complicated fungal infection; often it is life-threatening. Coccidioidomycosis is confined epidemiologically to the southwestern region of the USA, and most cases have occurred in that area, particularly in Arizona. However, we have seen several cases in San Francisco in patients with only a history of travel to endemic areas. In part because ofits regional distribution, information about the clinical presentation, diagnosis, and treatment ofpatients with coccidioidomycosis has lagged behind information about other, more commonly encountered AIDS-associated opportunistic infections. Drs. Galgiani and Ampel have probably had the largest single experience with coccidioidomycosis in individuals infected with the human immunodeficiency virus. These specialists share their experience and make recommendations as to how these complicated conditions should be approached.
AB - Note From Dr. Merle. A. Sande –Coccidioidomycosis is at best a complicated fungal infection; often it is life-threatening. Coccidioidomycosis is confined epidemiologically to the southwestern region of the USA, and most cases have occurred in that area, particularly in Arizona. However, we have seen several cases in San Francisco in patients with only a history of travel to endemic areas. In part because ofits regional distribution, information about the clinical presentation, diagnosis, and treatment ofpatients with coccidioidomycosis has lagged behind information about other, more commonly encountered AIDS-associated opportunistic infections. Drs. Galgiani and Ampel have probably had the largest single experience with coccidioidomycosis in individuals infected with the human immunodeficiency virus. These specialists share their experience and make recommendations as to how these complicated conditions should be approached.
UR - http://www.scopus.com/inward/record.url?scp=0025176081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025176081&partnerID=8YFLogxK
U2 - 10.1093/infdis/162.5.1165
DO - 10.1093/infdis/162.5.1165
M3 - Article
C2 - 2230241
AN - SCOPUS:0025176081
SN - 0022-1899
VL - 162
SP - 1165
EP - 1169
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 5
ER -